Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr517 Inhibitors

Olr517 inhibitors represent a distinct class of chemical compounds characterized by their ability to modulate the activity of the Olr517 protein. This protein, a member of the olfactory receptor family, is integral to the chemosensory systems in organisms, where it plays a critical role in the detection of chemical stimuli. The inhibition of Olr517 offers a fascinating perspective on understanding the molecular interactions and signaling pathways associated with olfactory receptors. Inhibitors targeting Olr517 typically possess specific structural features that allow them to bind selectively to this protein, thereby preventing it from engaging in its natural ligand interactions. The study of these inhibitors is of particular interest in the field of chemical biology, as they provide insights into the structure-function relationships that govern olfactory receptor activity.

The chemical structure of Olr517 inhibitors often includes heterocyclic frameworks or functional groups that facilitate their binding to the receptor's active site. Advanced techniques such as molecular docking and spectroscopic analyses are employed to explore the binding affinities and conformational changes induced by these inhibitors. Understanding these interactions at a molecular level is essential for unraveling the mechanisms by which Olr517 influences olfactory signal transduction. Additionally, the synthesis and characterization of Olr517 inhibitors contribute to the broader field of receptor biology, where the precise modulation of receptor activity is crucial for dissecting the roles of individual receptors within complex biological systems. Through this lens, Olr517 inhibitors offer a valuable tool for probing the intricate network of molecular signals that underlie the sensory perception of chemical stimuli.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

An mTOR inhibitor, potentially influencing proteins involved in cell growth and proliferation.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Inhibits EGFR tyrosine kinase, potentially affecting proteins in the EGFR signaling pathway.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Inhibits JAK1/2, potentially affecting proteins in cytokine signaling pathways.

Belinostat

414864-00-9sc-269851
sc-269851A
10 mg
100 mg
$156.00
$572.00
(1)

Inhibits histone deacetylases, potentially affecting gene expression and chromatin remodeling proteins.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

Inhibits MET, VEGFR, and RET, potentially affecting proteins in multiple signaling pathways.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Proteasome inhibitor, potentially affecting protein degradation and cell cycle regulation.

Lenvatinib

417716-92-8sc-488530
sc-488530A
sc-488530B
5 mg
25 mg
100 mg
$182.00
$661.00
$1690.00
3
(0)

Targets multiple tyrosine kinases, including VEGFR, potentially affecting angiogenesis-related proteins.

Niraparib

1038915-60-4sc-507492
10 mg
$150.00
(0)

PARP inhibitor, potentially affecting proteins involved in DNA repair pathways.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

Targets EGFR with T790M mutation, potentially affecting proteins in mutated EGFR pathways.

AP 24534

943319-70-8sc-362710
sc-362710A
10 mg
50 mg
$175.00
$983.00
2
(1)

Multi-targeted tyrosine kinase inhibitor, potentially influencing various cell signaling proteins.